USA FINANCIAL FORMULAS

Position in GILD — Gilead Sciences, Inc.

CIK 1633716 ADA, MI

Position in GILD

as of Mar 31, 2026 · filed Apr 14, 2026 Compact

Position Value

$1,366,383

+$256,200 QoQ

Shares Held

9,804

+8.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

USA FINANCIAL FORMULAS holds $3,801,551 across 6 Drug Manufacturers - General names. GILD ranks #1 (35.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	9,804	$1,366,383
2	MRK	Merck & Co., Inc.	7,410	$891,348
3	JNJ	Johnson & Johnson	2,894	$707,409
4	AMGN	Amgen Inc	1,862	$655,144
5	BMY	Bristol Myers Squibb Co	2,978	$180,615
6	ABBV	AbbVie Inc.	3	$652

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,366,383	9,804	+8.4%	Shares	Sole	2026-04-14
2025-12-31	$1,110,183	9,045	+14975.0%	Shares	Sole	2026-01-14
2025-09-30	$6,660	60	-99.8%	Shares	Sole	2025-10-10
2025-06-30	$3,345,613	30,176	+24.1%	Shares	Sole	2025-07-18
2025-03-31	$2,724,831	24,318	+45.9%	Shares	Sole	2025-04-15
2024-12-31	$1,539,253	16,664	-38.9%	Shares	Sole	2025-01-14
2023-09-30	$2,044,588	27,283	0.0%	Shares	Sole	2023-11-27
2023-06-30	$2,102,700	27,283	-33.6%	Shares	Sole	2023-11-27
2023-03-31	$3,411,643	41,119	+293607.1%	Shares	Sole	2023-11-27
2022-09-30	$863	14	-64.1%	Shares	Sole	2022-10-24
2022-06-30	$2,410	39	+178.6%	Shares	Sole	2022-08-15
2022-03-31	$832	14	-99.9%	Shares	Sole	2022-08-16
2021-12-31	$1,713,378	23,597	+40.0%	Shares	Sole	2022-02-10
2021-09-30	$1,177,182	16,853	—	Shares	Sole	2021-11-08
2020-09-30	$0	0	-100.0%	Shares	Sole	2020-10-09
2020-03-31	$3,342,145	44,705	—	Shares	Sole	2020-04-13
No filing history on record for this holder in this stock.